Prognostic value of stem-like circulating tumor cells in patients with cancer: a systematic review and meta-analysis

[1]  Yuping Zhang,et al.  ALDH1: A potential therapeutic target for cancer stem cells in solid tumors , 2022, Frontiers in Oncology.

[2]  Yiding Chen,et al.  Circulating tumor cells: biology and clinical significance , 2021, Signal Transduction and Targeted Therapy.

[3]  Kaitai Zhang,et al.  Telomerase-positive circulating tumor cells are associated with poor prognosis via a neutrophil-mediated inflammatory immune environment in glioma , 2021, BMC Medicine.

[4]  E. Obermayr,et al.  Cancer Stem Cell-Like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung Cancer , 2021, Journal of Personalized Medicine.

[5]  F. Xia,et al.  Association of Preoperative NANOG-Positive Circulating Tumor Cell Levels With Recurrence of Hepatocellular Carcinoma , 2021, Frontiers in Oncology.

[6]  S. Aziz,et al.  EMT, cancer stem cells and autophagy; The three main axes of metastasis. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[7]  T. Yevsa,et al.  Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies , 2020, Frontiers in Immunology.

[8]  Hung-Ming Wang,et al.  Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer , 2019, BMC Cancer.

[9]  V. Georgoulias,et al.  Prognostic Significance of TWIST1, CD24, CD44, and ALDH1 Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients , 2019, Cells.

[10]  S. Lee,et al.  Technologies for circulating tumor cell separation from whole blood , 2019, Journal of Hematology & Oncology.

[11]  T. Yen,et al.  The Prognostic Roles of Pretreatment Circulating Tumor Cells, Circulating Cancer Stem-Like Cells, and Programmed Cell Death-1 Expression on Peripheral Lymphocytes in Patients with Initially Unresectable, Recurrent or Metastatic Head and Neck Cancer: An Exploratory Study of Three Biomarkers in One-ti , 2019, Cancers.

[12]  Q. Huang,et al.  The viable circulating tumor cells with cancer stem cells feature, where is the way out? , 2018, Journal of experimental & clinical cancer research : CR.

[13]  H. Lenz,et al.  Clinical relevance of EMT and stem-like gene expression in circulating tumor cells of metastatic colorectal cancer patients , 2016, The Pharmacogenomics Journal.

[14]  Yuan Li,et al.  Prognostic value of CD133+ CD54+ CD44+ circulating tumor cells in colorectal cancer with liver metastasis , 2017, Cancer medicine.

[15]  K. Pantel,et al.  Biology and clinical significance of circulating tumor cell subpopulations in lung cancer. , 2017, Translational lung cancer research.

[16]  C. Blanpain,et al.  Cancer Stem Cells: Basic Concepts and Therapeutic Implications. , 2016, Annual review of pathology.

[17]  J. Massagué,et al.  Metastatic colonization by circulating tumour cells , 2016, Nature.

[18]  B. Dai,et al.  Combination of circulating tumor cell enumeration and tumor marker detection in predicting prognosis and treatment effect in metastatic castration-resistant prostate cancer , 2015, Oncotarget.

[19]  T. Gauler,et al.  Detection of Circulating Tumor Cell Subpopulations in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) , 2014, PloS one.

[20]  K. Pantel,et al.  Challenges in circulating tumour cell research , 2014, Nature Reviews Cancer.

[21]  Dan Luo,et al.  Stem Cell-Like Circulating Tumor Cells Indicate Poor Prognosis in Gastric Cancer , 2014, BioMed research international.

[22]  K. Pantel,et al.  Presence of EpCAM‐positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma , 2013, International journal of cancer.

[23]  Wai Leong Tam,et al.  The epigenetics of epithelial-mesenchymal plasticity in cancer , 2013, Nature Medicine.

[24]  Jing-jing Hu,et al.  Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells. , 2013, Gastroenterology.

[25]  R. Franco,et al.  Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer. , 2013, Oncology reports.

[26]  Tim Holland-Letz,et al.  Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay , 2013, Nature Biotechnology.

[27]  Klaus Pantel,et al.  Circulating tumor cells: liquid biopsy of cancer. , 2013, Clinical chemistry.

[28]  Gordon H Guyatt,et al.  GRADE guidelines: 7. Rating the quality of evidence--inconsistency. , 2011, Journal of clinical epidemiology.

[29]  K. Pantel,et al.  Clinical relevance and biology of circulating tumor cells , 2011, Breast Cancer Research.

[30]  J. Kowalski,et al.  Concise Review: Emerging Concepts in Clinical Targeting of Cancer Stem Cells , 2011, Stem cells.

[31]  R. Weinberg,et al.  A Perspective on Cancer Cell Metastasis , 2011, Science.

[32]  Mehmet Toner,et al.  Circulating tumor cells: approaches to isolation and characterization , 2011, The Journal of cell biology.

[33]  L. Frati,et al.  Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[34]  A. Stang Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses , 2010, European Journal of Epidemiology.

[35]  R. Iacovelli,et al.  Molecular markers in circulating tumour cells from metastatic colorectal cancer patients , 2010, Journal of cellular and molecular medicine.

[36]  Daniel Birnbaum,et al.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.

[37]  M. Sydes,et al.  Practical methods for incorporating summary time-to-event data into meta-analysis , 2007, Trials.

[38]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[39]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.